Painreform is trading 6.88% up at $1.01 in pre-market, with the catalyst unclear.
- No verified company-specific announcement dated September 9, 2026, was found to explain the move.
- The latest identified company update, released September 3, covered first-half results and business progress.
- The broader market was lower.